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INTRODUCTION
Diabetes mellitus is one of the most commonly encountered 
metabolic diseases in many parts of the world and is considered 
as an important health issue due to its relatively high prevalence 
and severe complications [1]. Hypertriglyceridemia is among the 
common metabolic derangements seen in people with type 2 
diabetes [2] and also may be a complication of uncontrolled type 
1 diabetes [3]. Hypertriglyceridemia causes atherosclerosis when 
Triglyceride (TG) levels are markedly increased [2]. Changes in the 
activity of enzymes involved in the maintenance of TGs homeostasis 
has a major role in this regard; for example increased lipolysis by 
HSL in the adipocytes due to lack of insulin synthesis or response 
in diabetes leads to increased release of fatty acids from adipocytes 
which increases VLDL synthesis in liver and consequently its higher 
concentration in bloodstream. Moreover, reduced scavenging 
of VLDL in type 1 diabetes occurs due to LPL dependency on 
insulin [4]. Peroxisome PPARα that regulates transcription of 
genes involved in lipid metabolism is also very important. PPARα 
activation leads to an increase in production of LPL associated with 
capillary endothelial cells in adipose tissue and consequently higher 
scavenging of VLDL. On the other hand, activation of PPARα in the 
liver stimulates oxidation of fatty acids, which reduces TG reserves 
and VLDL synthesis [5].
Although different classes of medications including Fibrates, 
Niacin, Statins etc., are currently used in the management of 
major TG elevations, the outcome is still far from perfect and 
sometimes the side effects are considerable. For instance, 
Fibrates as agonists of PPARα, decrease TG levels, however 
clinical trial results have been unconvincing with regards to their 
benefit [6] and consumption of Niacin has been associated with 
increased insulin resistance [2].
Therefore, finding safe and multifaceted agents with the potential 
to be used at least as adjunct therapy or included in the diet is 
persuaded. Cornelian cherry, botanically named Cornus mas 
L., belongs to the family Cornacea and the order Cornales. This 
plant grows in the Northern hemisphere, East Asia, East and North 
West America, East Africa, and Europe as well as Turkey, Iran, and 
Azerbaijan [7].
Among different positive health effects, this fruit has been shown 
to be helpful in treating hyperlipidemia [8]. In a small clinical 
trial by Soltani et al., daily consumption of the fruit extract 
reduced serum TG level in type 2 diabetic adult patients [9]. 
This motivated us to investigate the action mechanism of C. 
mas in ameliorating hypertriglyceridemia in diabetes with regard 
to serum LPL, adipose tissue HSL and hepatic PPARα levels in 
diabetic rats.
MATERIALS AND METHODS
An experimental study with parallel controls was accomplished at 
Shahrekord University of Medical Sciences (Shahrekord, Iran) and 
School of Veterinary Medicine, Shiraz University (Shiraz, Iran) from 
August 2015 to December 2016.
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ABSTRACT
Introduction: Hypertriglyceridemia is among the multiple 
metabolic derangements seen in diabetes mellitus. Cornelian 
cherry (Cornus mas L.), belongs to the family Cornacea and has 
been shown to be helpful in treating hyperlipidemia.
Aim: The study investigates mechanisms of action of dietary 
Cornelian Cherry fruit Dried Powder (CCDP) for ameliorating 
hypertriglyceridemia in diabetic rats.
Materials and Methods: An experimental study with parallel 
controls was performed. Fifty six male adult rats were randomly 
assigned into 8 equal groups and treated as follows for 4 
weeks. Negative control: Normal rats, basic diet; positive 
control: streptozotocin-induced diabetic rats, basic diet; T1 to 
T4 groups: diabetic rats fed with diets containing 0.25, 0.5, 1 
and 2 g/ 100 g BW CCDP, respectively; T5: diabetic rats fed with 
basic diet plus 100 mg/kg BW of fenofibrate in drinking water 
and T6: normal rats fed with basic diet containing 1 g/100 g 
BW CCDP. Selected serum biochemical parameters, Lipoprotein 
Lipase (LPL) level as well as Adipose Tissue Hormone Sensitive 
Lipase (HSL) and Hepatic Peroxisome Proliferator-Activated 
Receptor Alpha (PPARα) levels were assayed. Analysis of data 
was performed by one-way ANOVA followed by Tukey’s test 
with p<0.05 as the significant level.
Results: Treatment with CCDP at all dosages as well as 
fenofibrate decreased serum triglycerides and VLDL levels 
as compared to positive control. Serum AST significantly 
decreased in T1, T3 and T4 groups as compared to positive 
control rats. Serum LPL levels in the diabetic positive control 
group decreased significantly as compared to negative control. 
Rats in T1, T2, T4 and T5 groups showed increased serum LPL 
levels as compared to positive control. No significant difference 
was observed in hepatic PPARα levels among CCDP-treated 
and negative or positive controls. Positive control rats showed a 
significant decrease in adipose tissue HSL levels. Administration 
of CCDP in T3 group significantly increased HSL values as 
compared to positive control. CCDP in healthy rats did not 
change any of these parameters.
Conclusion: Findings of the present study confirms positive 
effects of C. mas fruit on some liver function enzymes and 
hypertriglyceridemia and clarifies that increased serum LPL 
levels is at least partly responsible for hypotriglyceridemic effect 
of the fruit in rats with STZ-induced diabetes mellitus.
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All procedures used in the present study were in accordance with 
institutional ethical guidelines for care and use of laboratory animals 
in experiments which are compatible with European convention for 
the protection of vertebrate animals used for experimental and other 
scientific purposes.
Determination of Biochemical Parameters
Sera were harvested by centrifugation of blood samples at 3000 
rpm for 10 min. serum concentrations of TG, VLDL, Alanine 
Aminotransferase (ALT) and Aspartate Aminotransferase (AST), 
were measured by commercially available kits (ParsAzmoon Co., 
Iran) in an auto analyser (Hitachi 902, Japan).
Measuring Serum LPL Level
Rat LPL ELISA kit (Zellbio, Germany) was used for measuring LPL. 
This assay was based on biotin double antibody sandwich technology 
using anti-rat LPL monoclonal antibody. Absorbance values were 
read at 450 nm and concentrations were calculated accordingly. The 
assay range of the kit was 0.1-40 U/L. Intra-assay and inter-assay 
precision of the kit (CV %) were <10% and <12%, respectively.
Measuring Hepatic PPARα and Adipose Tissue HSL 
Levels
Cellular membrane disintegration of adipose and hepatic tissue 
samples was accomplished by liquid nitrogen freeze-thawing 
procedure. One hundred mg of the tissue was homogenized in 
1 mL of PBS (pH=7.4, 100 Mm). The prepared suspension was 
centrifuged at 4000-6000 rpm for 10 minutes and supernatant was 
carefully removed. The amounts of PPARα in the liver and adipose 
tissue HSL were measured by rat sandwich ELISA kits (Zellbio, 
Germany) at 450 nm. The assay ranges of the kits were 0.5-40 ng/
mL (PPARα) and 0.3-90 ng/mL (HSL). Intra-assay and inter-assay 
precision (CV %) for both kits were <10% and <12%, respectively.
STATISTICAL ANALYSIS
Analysis of data were performed by one-way analysis of variance 
(ANOVA) followed by Tukey’s multiple comparison test in SPSS software 
and the significant level for differences was considered to be p<0.05.
RESULTS
Phytochemical Parameters
The assayed amounts were 13.6 mg/g for phenolic compounds, 
4.82 mg/g for flavonoids and 15 mg/mL for anthocyanins with IC50 
of 1.89 µg/mL.
Biochemical Parameters
As shown in [Table/Fig-2], serum levels of FBS, TGs, VLDL, ALT, 
and AST in the diabetic control group increased significantly as 
compared to negative control rats (p<0.001 for all comparisons). 
Treatment with 0.25, 0.5, 1, and 2 g/100 g BW of CCDP as well as 
fenofibrate caused a significant decrease in serum TG and VLDL 
levels in the diabetic rats as compared to positive control animals 
(p<0.001). According to the findings, different dosages of CCDP 
and fenofibrate caused statistically similar decrease in TG and VLDL 
levels, but serum TG and VLDL levels in C. mas-treated healthy 
rats did not change as compared to the healthy control rats. CCDP 
did not significantly change  blood glucose level in diabetic or 
healthy rats (p>0.05).  CCDP at 0.25, 1, and 2 g/100 g BW as well 
as fenofibrate caused a significant decrease in AST in the diabetic 
rats as compared to positive control group (p<0.001). CCDP had 
no effect on AST levels in the healthy rats. The results showed 
statistically the same effect of fenofibrate and 0.25, 1, and 2 g/100 
g BW of CCDP on serum ALT and AST levels in the diabetic rats. 
CCDP had no significant effect on serum levels of ALT in diabetic 
rats as compared to positive control as well as normal rats as 
compared to negative control animals (p>0.05).
Preparation of Cornelian Cherry Dried Powder (CCDP)
Cornelian cherry fruits were bought from the market in August-
September, 2015. The quality, genus and species were confirmed 
by a botanist and a sample is available in the Medicinal Plants 
Research Herbarium of the Shahrekord University of Medical 
Sciences (herbarium code: 201). Fruits were washed and dried by a 
freeze dryer system. The fruit powder was then mixed with ground 
standard feed of different groups.
Phytochemical evaluation: Folin-Ciocalceu reagent and 
colorimetric method were used to measure the amounts of 
phenolic compounds and flavonoids (in terms of rutin) in C. mas 
extract [10,11].
Total anthocyanin amount in C. mas was measured using a 
spectrophotometric differential pH method and total anthocyanin 
content was expressed in mg cyanidin 3-glucoside/mL [12].
The 1,1-Diphenyl-2-Picrylhydrazyl (DPPH) and Reducing Power 
Assay (RPA) were used for measurement of antioxidant activity of this 
fruit [13] which was expressed as IC50 that indicates the concentration 
of compound that causes 50% inhibition in oxidant capacity.
animals and study design: Fifty six male Wistar rats weighing 230±30 
g were housed under standard light and temperature conditions with 
free access to commercial feed and tap water for two weeks in order 
to adapt. They were then randomly assigned into 8 equal groups and 
fed with the following dietary regimens for 4 weeks.
Negative control (normal rats, corn-soy based diet as basic diet); 
positive control (diabetic rats, basic diet), T1 to T4 groups: diabetic 
rats that were fed with basic diet containing 0.25, 0.5, 1 and 2 g/100 
g BW CCDP, respectively; T5 (comparative control): diabetic rats that 
were fed with basic diet plus 100 mg/kg BW of fenofibrate (Sigma-
Aldrich, St. Louis, USA) in drinking water [14] and T6: normal rats 
that were fed with basic diet containing 1 g/100 g BW CCDP. The 
analysis of basic diet is presented in [Table/Fig-1].
Humidity (%) 9.9
Dry matter (%) 90.1
Crude fat (%) 3.4
Crude protein (%) 21.5
Crude fiber (%) 3.4
Ash (%) 5.35
NaCl (%) 0.37
Calcium (%) 0.93
Phosphorus (%) 0.73
Nitrogen-free extract (%) 56.4
Total digestible nutrients (%) 75.5
Digestible energy (Kcal/Kg) 3330
Metabolisable energy (Kcal/Kg) 2910
[Table/Fig-1]: The analysis of basic diet.
Diabetes was induced by intraperitoneal (i.p.) Injection of 
Streptozotocin (STZ) (Sigma Aldrich Co., St Louis, USA) dissolved in 
0.1 M cold sodium citrate buffer, pH 4.5, (60 mg/kg body weight) as 
previously described [15]. Blood sampling by tail clip was performed 
on day 7 after STZ administration and Fasting Blood Sugar (FBS) 
level was determined by a glucometer (Biotech Co., Ltd., Hsinchu, 
Taiwan). Rats with blood glucose level >300 mg/dL were considered 
diabetic and were included in the study. This procedure was also 
repeated at the end of the experiment (28 days later).
After 4 weeks, the animals were anesthetized and then euthanized 
with 10% chloral hydrate (Sigma Aldrich Co., St Louis, USA) 
(0.3 mL/100 g BW, i.p.) after an overnight fasting. Blood samples 
were collected from the heart during anesthesia and liver and 
visceral fat samples were immediately removed and stored at -70°C 
until analysis.
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nC PC T1 T2 T3 T4 T5 T6
FBS (mg/dL) 159±19.0* 506±115 494±45.7 460±100 508±43.2 448±102 501±74.9 147±32.5*
TG (mg/dL) 60.1±13.7* 694±242 123±42.9* 47±10.8* 57.2±18.2* 43.1±8.29* 54.7±9.63* 55.4±12.5*
VLDL (mg/dL) 12.02±2.75* 138±48.5 24.6±8.58* 9.40±2.16* 11.4±3.65* 8.62±1.65* 14.8±7.67* 11.1±2.50*
ALT (U/L) 202±98.2* 627±324 546±59.3 523±312 348±86.3 388±149 134±83.5* 187±51.3*
[Table/Fig-2]: Serum biochemical parameters (mean±SD) of different groups. NC: Negative control (normal rats, basic diet); PC: positive control (diabetic rats, basic diet), 
T1 to T4 groups: diabetic rats that were fed with basic diet containing 0.25, 0.5, 1 and 2 g/100 g BW CCDP, respectively; T5 (comparative control): diabetic rats that were fed 
basic diet plus 100 mg/kg BW of fenofibrate and T6: normal rats that were fed with basic diet containing 1 g/100 g BW CCDP.
Asterisk sign is used to demonstrate significant difference with PC group (p<0.05).
Serum LPL Levels
As illustrated in [Table/Fig-3], LPL levels in the diabetic positive 
control group decreased significantly as compared to negative 
control group (p=0.021). Treatment with 0.25, 0.5, and 2 g/100 g 
BW of CCDP and 100 mg/kg of fenofibrate in diabetic rats caused 
a significant increase in serum LPL as compared to positive control 
group (p=0.014, p<0.001, p=0.001 and p=0.003, respectively) while 
CCDP alone had no appreciable effect in healthy rats as compared 
to negative control animals (p>0.05). No significant difference in LPL 
level was observed among fenofibrate-treated and CCDP-treated 
diabetic groups (p>0.05).
[Table/Fig-3]: Serum lipoprotein lipase (LPL) levels (mean±SD) in different groups. 
NC: Negative control (normal rats, basic diet); PC: positive control (diabetic rats, 
basic diet), T1 to T4 groups: diabetic rats that were fed with basic diet containing 
0.25, 0.5, 1 and 2 g/100 g BW CCDP, respectively; T5 (comparative control): diabetic 
rats that were fed basic diet plus 100 mg/kg BW of fenofibrate and T6: normal rats 
that were fed with basic diet containing 1 g/ 100 g BW CCDP.
Asterisk sign is used to demonstrate significant difference with PC group (*p<0.05, **p<0.01, 
***p<0.001).
Liver PPARα and Adipose Tissue HSL Levels
[Table/Fig-4] shows liver concentration of PPARα in different 
groups. Induction of diabetes resulted only in a trivial increase in 
PPARα level in liver of rats in positive control group as compared 
to negative control rats (p>0.05). No significant difference was 
observed among CCDP-treated and negative or positive control rats 
(p>0.05). Interestingly, fenofibrate administration was associated 
with an appreciable increase in PPARα concentration as compared 
to negative control, T1 and T6 animals (p=0.011, p=0.027 and 
p=0.018, respectively).
As demonstrated in [Table/Fig-5], diabetes was associated with 
a significant decrease in adipose tissue HSL levels as compared 
to negative control group (p=0.021). Although administration of 
CCDP at all four dosages increased HSL value as compared to 
positive control group, the increase was only significant in 1 mg/100 
g BW (T3) group (p=0.007) and other CCDP-treated groups had 
statistically the same values of HSL as compared to both negative 
and positive control groups (p>0.05). Fenofibrate administration 
had no appreciable effect on HSL values as compared to positive 
control rats (p>0.05) and rats in this group showed significant 
difference with negative control group (p=0.003). CCDP alone did 
not significantly change HSL level as compared to negative control 
group (p>0.05).
[Table/Fig-4]: Concentrations of peroxisome proliferator-activated receptor α 
(PPARα) (mean±SD) in liver of different groups. NC: Negative control (normal rats, 
basic diet); PC: Positive Control (diabetic rats, basic diet), T1 to T4 groups: diabetic 
rats that were fed with basic diet containing 0.25, 0.5, 1 and 2 g/100 g BW CCDP, 
respectively; T5 (comparative control): diabetic rats that were fed basic diet plus 
100 mg/kg BW of fenofibrate and T6: normal rats that were fed with basic diet 
 containing 1 g/100 g BW CCDP.
No significant difference was observed between PC rats and other groups (p>0.05).
[Table/Fig-5]: Concentrations of Hormone-Sensitive Lipase (HSL) (mean±SD) in 
adipose tissue of different groups. NC: Negative control (normal rats, basic diet); 
PC: positive control (diabetic rats, basic diet), T1 to T4 groups: diabetic rats that 
were fed with basic diet containing 0.25, 0.5, 1 and 2 g/100 g BW CCDP, respectively; 
T5 (comparative control): diabetic rats that were fed basic diet plus 100 mg/kg BW of 
fenofibrate and T6: normal rats that were fed with basic diet containing 1 g/100 g BW 
CCDP.
Asterisk sign is used to demonstrate significant difference with PC group (*p<0.05, **p<0.01).
DISCUSSION
Hypertriglyceridemia is a metabolic derangement in type 2 diabetes 
[2] and also may be a complication of uncontrolled type 1 diabetes [3]. 
Unfortunately, currently available hypolipidemic drugs are associated 
with relatively serious side effects and do not consistently keep the 
normolipidemic states nor completely prevent late complications of 
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diabetic hyperlipidemia [16]. With alarmingly increased prevalence 
of diabetes and associated costs, interest in alternative therapies 
including medicinal plants has grown extensively [17]. Chemical 
compounds isolated from medicinal plants provide opportunities 
to further develop therapeutic strategies. Cornelian cherry fruits 
have various nutritional and medicinal benefits [18]. The fruit is rich 
in anthocyanins, phenolic and flavonoid compounds, the amounts 
of which depend on plant genotype, weather and geographical 
conditions as well as fruit ripeness [19]. As previously stated in the 
current study, the amounts of these main chemical compounds in our 
samples were relatively high with 13.6 mg/g (phenolic compounds), 
4.82 mg/g (flavonoids) and 15 mg/mL (anthocyanins) with antioxidant 
capacity (IC50) of 1.89 µg/mL. Other researchers have reported 
different values; for example Pawlowska AM et al., reported that the 
amount of flavonoids present in C. mas gathered in Italy in September 
was 22.1 mg/g [20]. A study by Tural S et al., demonstrated that 
the amounts of phenolic compounds and anthocyanins, as well as 
antioxidant capacity of C. mas gathered in Turkey in September were 
4.37 mg/g, 1.97 mg/g, and 0.5 mg/ml, respectively [21]. The relative 
inconsistency in these findings is probably due to the effect of the 
region and time of gathering the samples.
It has been demonstrated that in STZ-induced diabetic rats 
triglyceride levels of liver and kidney shows a significant reduction 
which may be due to an increased mobilisation of lipids from these 
tissues or a decrease in fatty acid uptake and storage capacity that 
increase serum TGs [22]. This can describe changes in serum TGs 
and VLDL levels in diabetic rats as observed in the current study.
In this study, administration of 0.25, 0.5, 1, and 2 g/100 g BW of 
CCDP caused significant decrease in serum VLDL and TGs levels 
as compared to positive control rats. This is consistent with the 
study performed by Rafieian-Kopaei M et al., where administration 
of cornelian cherry in diet resulted in a reduction of TGs levels of 
atherosclerotic rabbits [23]. Unfortunately the mechanism of this 
effect was not investigated by these authors.
Lipoprotein lipase has a pivotal role in lipid metabolism. It hydrolyzes 
TGs in lipoprotein particles and provides fatty acids for peripheral 
tissues. Serum level of preheparin LPL reflects LPL production mainly in 
adipocytes [24] and correlates negatively with serum TG and positively 
with High-Density Lipoprotein-Cholesterol (HDL-C) [25]. Decreased 
activity of LPL is important in diabetic dyslipidemia [26]. In the present 
study, STZ-induced diabetes resulted in a significant decrease in 
serum LPL level which was reversed by fenofibrate administration. It 
is well established that PPARα and PPARγ agonists are transcriptional 
regulators of LPL expression [27] which describes the effect of 
fenofibrate (a PPARα agonist) on LPL level in our study. Interestingly, 
treatment of diabetic rats with CCDP at all four dosages also reversed 
this change. Therefore, increased LPL level may be considered as 
a mechanism for hypotriglyceridemic activity of cornelian cherry. 
Increased expression of LPL has also been previously described as a 
hypolipidemic activity of herbs; for instance Chao CY et al., showed 
that wild bitter gourd extract up-regulates mRNA expression of LPL in 
the epididymal adipose tissue of mice [28].
In vitro investigations have indicated that flavonoids increase 
expression of LPL in adipose tissue and muscle cells [29]. Besides, 
high doses of phenolic compounds have been demonstrated to 
prevent hyperlipidemia in rats through significant increase in LPL 
activity [30]. Therefore, effect of CCDP on LPL can be explained by 
the presence of flavonoids and poly phenolic compounds in this fruit.
PPARα is highly expressed in liver and its activation is associated 
with increased hepatic lipid uptake and oxidation [31]. As previously 
stated in our study hepatic PPARα level only showed a tendency to 
increase in diabetic rats as compared to negative control animals 
(p=0.092) and neither CCDP nor fenofibrate appreciably affected this 
parameter as compared to positive control rats, although hepatic 
PPARα levels were slightly lower in CCDP groups. Studies that have 
investigated hepatic PPARα levels in diabetic models are scarce. In 
a very recent study, Tong J et al., reported that treating HepG2 cells 
with glucose increases PPARα mRNA levels which is down regulated 
by a fraction of Cichorium glandulosum seed extract [32]. This report 
may be at least partially consistent with our results although different 
methods and study conditions may be important considerations.
Hormone sensitive lipase is an intracellular lipase enzyme which is 
highly expressed in adipose tissue and is capable of hydrolyzing 
triacylglycerols, diacylglycerols, monoacylglycerols, and cholesteryl 
esters, as well as other lipid and water soluble substrates [33]. We 
did not find a study that had evaluated the HSL protein concentration 
in insulin deficient models; however previous studies show that HSL 
protein and mRNA expression is decreased in adipose tissues of 
humans with insulin resistant states [34]. HSL activity is acutely 
controlled by reversible phosphorylation which is antagonized by 
insulin [35]. Therefore, HSL activity increases in insulin deficiency 
which at least hypothetically can lead to reduced HSL mRNA and 
protein expression. This can describe the reduction which was 
observed in adipose tissue HSL protein level of diabetic rats of 
our study, although it remains to be confirmed in future studies. 
Administration of CCDP increased HSL level especially in rats 
treated with 1 g/100 g BW (T3). This may be related to a change in 
insulin level which unfortunately was not assayed in our study.
Toxic and destructive effects of STZ have not only been detected in 
pancreatic islet beta cells but may also involve other organs such as 
the liver [36]. Liver is one of the main targets of insulin action and plays 
an important role in maintaining and stabilizing blood glucose levels 
[37]. Changes observed in the liver are not exclusively due to toxic 
effects of STZ; rather, they are induced mainly by complications due 
to diabetes. STZ causes hepatotoxicity via producing free radicals 
and subsequently lipids peroxidation in hepatocytes membrane [38].
Increased activity of plasma ALT and AST is most probably due 
to liver dysfunction [39] and leakage of these enzymes into the 
bloodstream during diabetes [40]. ALT and AST are good markers 
to measure the rate of hepatocytes damage [41]. In the early steps 
of liver destruction, hepatocytes cytoplasmic enzymes probably 
leak from the cells into the bloodstream and membrane permeability 
increases [42]. Moreover, increased catabolism of proteins alongside 
gluconeogenesis and urea production that occur in diabetes is 
probably responsible for increase in these transaminases in the 
blood. In addition, because insulin suppresses gluconeogenetic 
enzyme-producing genes and ALT is a gluconeogenic enzyme, the 
production of this enzyme increases during diabetes when insulin 
signaling becomes defective. This condition can be even unrelated 
to liver injury [43].
In the present study, two liver enzymes, i.e., ALT and AST, increased 
significantly in the diabetic rats as compared to the negative control 
group. Treatment with CCDP improved serum levels of AST. 
Consistently, it has been previously shown that administration of 
hydro alcoholic extract of cornelian cherry fruit decreases serum 
ALT and AST levels in diabetic rats [44].
LIMITATION
Possible effects on the function of the enzymes which are involved 
in metabolism of TGs, apolipoprotein synthesis and metabolism, TG 
absorption from gastrointestinal tract etc., are main determinants 
that could be considered as potential mechanisms of the 
hypotriglyceridemic activity of C. mas which are not assayed in the 
current study and remain to be evaluated in future.
CONCLUSION
In conclusion, findings of the present study confirms positive 
effects of C. mas fruit on some liver function enzymes and 
hypertriglyceridemia and clarifies that increased serum LPL levels is 
at least partly responsible for hypotriglyceridemic effect of the fruit in 
rats with STZ-induced diabetes mellitus.
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